Arkolith/Insider Trading/AXIM/Form 4

Valencia Catalina

President and Director, Director, 10% OwnerAXIM BIOTECHNOLOGIES, INC. (AXIM) · full profile →Form 4 · filed Oct 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2024Buy(P)1.1M——28.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001096906-24-002004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML